• Application Note

Diltiazem HCL

Diltiazem HCL

  • Waters Corporation

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief demonstrates the analysis of diltiazem HCL using Symmetry Columns.  

Introduction

The compound analyzed in this study is diltiazem HCL.  

Experimental

HPLC Method

Column:

Symmetry C8, 3.9 x 150 mm, 5 µm

Guard Column:

Symmetry Guard Column 3.9 x 20 mm, 5 µm

Part numbers:

Column - WAT046970, Guard - WAT054250

Mobile phase:

100 mM sodium acetate, 5mM camphosulfonic acid, pH 6.2/acetonitrile/methanol 40:30:30

Flow rate:

1.0 mL/min

Injection volume:

10 µL of 50 µg/mL sample

Detection:

UV @ 254 nm

USP Tailing Factors

  1. 1.08 

Results and Discussion

Featured Products

WA31763.75, June 2003

Back To Top Back To Top